These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 6125621)
41. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Frishman W Am Heart J; 1979 May; 97(5):663-70. PubMed ID: 34989 [No Abstract] [Full Text] [Related]
42. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
43. [Treatment of arrhythmias with practolol (Eraldin)]. Van Durme JP; Bossaert L; Vermeire P; Pannier R G Ital Cardiol; 1972; 2(1):161-2. PubMed ID: 4401034 [No Abstract] [Full Text] [Related]
44. The use of beta-adrenergic receptor blockade in the treatment of cardiac arrhythmias. Pitt B Md State Med J; 1970 Jul; 19(7):30-1. PubMed ID: 4399737 [No Abstract] [Full Text] [Related]
45. Treatment of ventricular arrhythmias in heart failure: drugs or devices. Gambhir DS Indian Heart J; 1998; 50(5):507-10. PubMed ID: 10052273 [No Abstract] [Full Text] [Related]
50. Classification of antiarrhythmic drugs. Kutalek SP; McCormick DJ Am Fam Physician; 1988 Oct; 38(4):261-6. PubMed ID: 2902778 [No Abstract] [Full Text] [Related]
51. Use of anti-arrhythmic agents other than digitalis. Dreifus LS Nebr State Med J; 1970 Dec; 55(12):742-4. PubMed ID: 4395040 [No Abstract] [Full Text] [Related]
52. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency]. Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207 [No Abstract] [Full Text] [Related]
53. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias. Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120 [TBL] [Abstract][Full Text] [Related]
55. Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations. Obel OA Resuscitation; 2000 Aug; 45(3):S7-S10. PubMed ID: 10959028 [No Abstract] [Full Text] [Related]
56. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro]. Ledda F; Mantelli L G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868 [TBL] [Abstract][Full Text] [Related]
57. [Current classification of anti-arrhythmia agents]. Weirich J; Wenzel W Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787 [TBL] [Abstract][Full Text] [Related]
58. The beat goes on: on the importance of heart rate in chronic heart failure. Swedberg K; Komajda M Eur Heart J; 2012 May; 33(9):1044-5. PubMed ID: 22408032 [No Abstract] [Full Text] [Related]
59. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease. Harrison DC Drugs; 1974; 7(1):1-7. PubMed ID: 4152164 [No Abstract] [Full Text] [Related]